Wu Di - Net Worth and Insider Trading

Wu Di Net Worth

The estimated net worth of Wu Di is at least $1 Million dollars as of 2024-09-23. Wu Di is the Executives of Realcan Pharmaceutical Group Co Ltd and owns about 540,600 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) stock worth over $1 Million. Details can be seen in Wu Di's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wu Di has not made any transactions after 2018-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Wu Di

To

Wu Di Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wu Di owns 1 companies in total, including Realcan Pharmaceutical Group Co Ltd (SZSE:002589) .

Click here to see the complete history of Wu Di’s form 4 insider trades.

Insider Ownership Summary of Wu Di

Ticker Comapny Transaction Date Type of Owner
SZSE:002589 Realcan Pharmaceutical Group Co Ltd 2018-12-26 Executives

Wu Di Latest Holdings Summary

Wu Di currently owns a total of 1 stock. Wu Di owns 540,600 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) as of December 26, 2018, with a value of $1 Million.

Latest Holdings of Wu Di

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:002589 Realcan Pharmaceutical Group Co Ltd 2018-12-26 540,600 2.31 1,248,786

Holding Weightings of Wu Di


Wu Di Form 4 Trading Tracker

According to the SEC Form 4 filings, Wu Di has made a total of 0 transactions in Realcan Pharmaceutical Group Co Ltd (SZSE:002589) over the past 5 years. The most-recent trade in Realcan Pharmaceutical Group Co Ltd is the acquisition of 80,900 shares on December 26, 2018, which cost Wu Di around $557,401.

Insider Trading History of Wu Di

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wu Di Trading Performance

GuruFocus tracks the stock performance after each of Wu Di's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wu Di is -12.33%. GuruFocus also compares Wu Di's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wu Di within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Wu Di's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Wu Di

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.48 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -17.05 LIMIT LIMIT LIMIT LIMIT LIMIT

Wu Di Ownership Network

Ownership Network List of Wu Di

No Data

Ownership Network Relation of Wu Di

Insider Network Chart

Wu Di Owned Company Details

What does Realcan Pharmaceutical Group Co Ltd do?

Who are the key executives at Realcan Pharmaceutical Group Co Ltd?

Wu Di is the Executives of Realcan Pharmaceutical Group Co Ltd. Other key executives at Realcan Pharmaceutical Group Co Ltd include Directors & executives Zhang Ren Hua , Directors & Directors & and Executives Zhou Yun , and Executives Su Li Chen .

Realcan Pharmaceutical Group Co Ltd (SZSE:002589) Insider Trades Summary

Over the past 18 months, Wu Di made no insider transaction in Realcan Pharmaceutical Group Co Ltd (SZSE:002589). Other recent insider transactions involving Realcan Pharmaceutical Group Co Ltd (SZSE:002589) include a net sale of 0 shares made by Zhang Ren Hua , and a net sale of 2,000,000 shares made by Han Xu .

In summary, during the past 3 months, insiders sold 0 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,000,000 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,000,000 shares.

Realcan Pharmaceutical Group Co Ltd (SZSE:002589)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Realcan Pharmaceutical Group Co Ltd Insider Transactions

No Available Data

Wu Di Mailing Address

Above is the net worth, insider trading, and ownership report for Wu Di. Currently GuruFocus does not have mailing address information for Wu Di.